Verrica Pharmaceuticals Inc.
VRCA
$0.4891
$0.02264.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 46.33M | 22.96M | 31.93M | 48.94M | 69.55M |
| Total Receivables | 77.00K | 84.00K | 10.21M | 7.59M | 4.42M |
| Inventory | 2.46M | 2.58M | 2.70M | 2.50M | 1.02M |
| Prepaid Expenses | 2.31M | 2.56M | 2.48M | 2.34M | 2.55M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 51.18M | 28.19M | 47.32M | 61.38M | 77.53M |
|
|
|||||
| Total Current Assets | 51.18M | 28.19M | 47.32M | 61.38M | 77.53M |
| Net Property, Plant & Equipment | 2.58M | 4.20M | 4.24M | 4.48M | 3.62M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 376.00K | 538.00K | 453.00K | 452.00K | 452.00K |
| Total Assets | 54.13M | 32.93M | 52.01M | 66.31M | 81.60M |
|
|
|||||
| Total Accounts Payable | 1.90M | 966.00K | 1.15M | 2.53M | 2.46M |
| Total Accrued Expenses | 3.09M | 6.06M | 4.93M | 6.91M | 8.17M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.61M | 1.16M | 1.05M | 1.01M | 700.00K |
| Total Finance Division Other Current Liabilities | 10.42M | 12.84M | 12.92M | 8.92M | 5.69M |
| Total Other Current Liabilities | 10.42M | 12.84M | 12.92M | 8.92M | 5.69M |
| Total Current Liabilities | 29.01M | 21.03M | 20.05M | 19.37M | 17.02M |
|
|
|||||
| Total Current Liabilities | 29.01M | 21.03M | 20.05M | 19.37M | 17.02M |
| Long-Term Debt | 30.98M | 43.31M | 42.75M | 42.85M | 42.87M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.35M | 2.65M | 2.51M | 2.59M | 1.94M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.65M | -- | -- | -- | -- |
| Total Liabilities | 63.99M | 66.98M | 65.31M | 64.80M | 61.83M |
|
|
|||||
| Common Stock & APIC | 297.17M | 256.77M | 254.67M | 252.29M | 250.21M |
| Retained Earnings | -307.03M | -290.83M | -267.97M | -250.78M | -230.45M |
| Treasury Stock & Other | -- | -- | -- | -4.00K | -- |
| Total Common Equity | -9.86M | -34.05M | -13.30M | 1.51M | 19.76M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.86M | -34.05M | -13.30M | 1.51M | 19.76M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.86M | -34.05M | -13.30M | 1.51M | 19.76M |
|
|
|||||